Cargando…
Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts–a paired sample study
Mesenchymal stem cells (MSCs) show immunoregulatory properties. Here, we compared MSCs obtained from placenta (P-MSCs) and umbilical cord (C-MSCs) from the same donor, for their immunomodulatory efficacy. P-MSCs and C-MSCs showed similar morphology and phenotypic profile, but different clonogenic ab...
Autores principales: | Talwadekar, Manasi D., Kale, Vaijayanti P., Limaye, Lalita S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623529/ https://www.ncbi.nlm.nih.gov/pubmed/26507009 http://dx.doi.org/10.1038/srep15784 |
Ejemplares similares
-
Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells
por: Kadekar, Darshana, et al.
Publicado: (2015) -
Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy
por: Kumar, Jeetendra, et al.
Publicado: (2015) -
Conditioned Medium from Placental Mesenchymal Stem Cells Reduces Oxidative Stress during the Cryopreservation of Ex Vivo Expanded Umbilical Cord Blood Cells
por: Kadekar, Darshana, et al.
Publicado: (2016) -
Expansion of Cord Blood CD34(+) Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse
por: M, Sangeetha V., et al.
Publicado: (2010) -
Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
por: Shinde, Prajakta, et al.
Publicado: (2018)